EGS Healthcare Capital Partners logo

EGS Healthcare Capital Partners

North America, Connecticut, United States, Norwalk

Description

EGS Healthcare Capital Partners is a healthcare private equity firm that invests in late stage private and emerging public healthcare

Investor Profile

EGS Healthcare Capital Partners has made 10 investments, with 0 in the past 12 months and 10% as lead.

Stage Focus

  • Series B (60%)
  • Series Unknown (20%)
  • Series C (10%)
  • Series A (10%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Medical
  • Medical Device
  • Biotechnology
  • Pharmaceutical
  • Manufacturing
  • Wellness
  • Clinical Trials
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does EGS Healthcare Capital Partners frequently co-invest with?

Oakwood Medical Investors
North America, Missouri, United States, St Louis
Co-Investments: 2
The Carlyle Group
North America, District of Columbia, United States, Washington
Co-Investments: 2
FCA Venture Partners
North America, Tennessee, United States, Brentwood
Co-Investments: 1
Mitsui Global Investment
North America, California, United States, Menlo Park
Co-Investments: 2
NGN Capital
North America, New York, United States, New York
Co-Investments: 3
Morgan Stanley Expansion Capital
North America, New York, United States, New York
Co-Investments: 2
MedVenture Associates
North America, California, United States, Emeryville
Co-Investments: 3
MDS Capital
North America, New York, United States, New York
Co-Investments: 1
MT
Europe, Ile-de-France, France, Paris
Co-Investments: 1
MB Venture Partners
North America, Tennessee, United States, Memphis
Co-Investments: 1

What are some of recent deals done by EGS Healthcare Capital Partners?

EKOS Corporation

Bothell, Washington, United States

EKOS Corporation provides a system for the treatment of vascular thrombosis.

Health CareMedicalMedical Device
Series CMar 21, 2006
Amount Raised: $26,000,000
OptiScan Biomedical

Hayward, California, United States

OptiScan Biomedical develops glucose monitoring systems to assist healthcare providers to manage the glucose level of the patients.

BiotechnologyHealth CareMedical
Series UnknownOct 10, 2005
Amount Raised: $36,000,000
Cerexa Inc.

New York, New York, United States

Cerexa is a biopharmaceutical company produces a portfolio of anti-infective therapies for the treatment of life-threatening infections.

BiotechnologyHealth CareMedicalPharmaceutical
Series AAug 23, 2005
Amount Raised: $50,000,000
Endius

Plainville, Massachusetts, United States

Endius provides less traumatic and more effective surgery for the patients treated for back pain.

Health CareManufacturingMedicalMedical DeviceWellness
Series UnknownMay 23, 2005
Amount Raised: $15,000,000
EKOS Corporation

Bothell, Washington, United States

EKOS Corporation provides a system for the treatment of vascular thrombosis.

Health CareMedicalMedical Device
Series BFeb 18, 2005
Amount Raised: $18,000,000
Alveolus

Charlotte, North Carolina, United States

Alveolus is a leader in the emerging field of non-vascular interventional stenting through next generation stent technology.

Medical
Series BJul 30, 2004
Amount Raised: $10,000,000
Jazz Pharmaceuticals

Palo Alto, California, United States

Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments.

BiotechnologyHealth CarePharmaceutical
Series BMar 24, 2004
Amount Raised: $250,000,000
Endius

Plainville, Massachusetts, United States

Endius provides less traumatic and more effective surgery for the patients treated for back pain.

Health CareManufacturingMedicalMedical DeviceWellness
Series BMar 26, 2003
Amount Raised: $26,500,000
Ardais Corporation

Lexington, Massachusetts, United States

Ardais Corporation, a leading clinical genomics company, is dedicated to enhancing and accelerating biomedical research.

BiotechnologyClinical TrialsGeneticsHealth Care
Series BMar 20, 2001
Amount Raised: $33,500,000
CytoLogix

Cambridge, Massachusetts, United States

CytoLogix is a private company that focuses on developing laboratory instrumentation for non-routine complex stains.

Health CareMedicalMedical Device
Series BJan 29, 2001
Amount Raised: $27,400,000